Literature DB >> 6284973

Synthesis of vesicular stomatitis virus negative-strand RNA in vitro: dependence on viral protein synthesis.

N L Davis, G W Wertz.   

Abstract

An in vitro system is described which supports the synthesis of vesicular stomatitis virus (VSV) negative-strand RNA. The major components of this system are (i) an mRNA-dependent rabbit reticulocyte lysate to carry out cell-free protein synthesis, (ii) the five VSV mRNAs to program VSV-specific protein synthesis, and (iii) nucleocapsids containing positive- and negative-strand genome-length RNA. The protein products synthesized in the system in response to addition of saturating amounts of the five VSV mRNA's included polypeptides which comigrated in acrylamide gels with the five VSV proteins. Approximately 200 pmol of protein per ml was synthesized during a 90-min reaction. The RNA products synthesized in the system included all five of the VSV mRNA's and, in addition, negative-strand, genome-sense RNA. All of the negative-strand RNA, which represented 2 to 5% of the total RNA product synthesized in vitro, banded in CsCl at the position of nucleocapsids. All of the mature mRNA's made in the system pelleted in CsCl. This technique allowed a clear separation of negative-strand product from the mRNA products and facilitated further analysis of the negative-strand product. The amount of negative-strand product produced in the system was shown to be a function of the amount of concurrent protein synthesis in the system. An increase in the level of protein synthesis led to an increase in the amount of negative-strand RNA synthesized, whereas inhibition of protein synthesis by cycloheximide resulted in a 70% inhibition of negative-strand synthesis. In contrast to the negative-strand RNA product, the amount of transcriptive product was decreased by 50% in the presence of maximum levels of viral protein synthesis. This inhibition was reversed by adding cycloheximide. Characterization of the negative-strand product by Northern blot analysis demonstrated that negative-strand product was being synthesized which hybridized to all five of the VSV mRNA's and, hence, that product representing all of the VSV cistrons was being made. This in vitro system offers an opportunity to study factors involved in the promotion of VSV genome replication as well as those responsible for the regulation of transcription.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6284973      PMCID: PMC256819     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing.

Authors:  D S Shih; C T Shih; D Zimmern; R R Rueckert; P Kaesberg
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

2.  Full-length viral RNA synthesized in vitro by vesicular stomatitis virus-infected HeLa cell extracts.

Authors:  S Batt-Humphries; C Simonsen; E Ehrenfeld
Journal:  Virology       Date:  1979-07-15       Impact factor: 3.616

3.  Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; Y Yu
Journal:  J Virol       Date:  1975-06       Impact factor: 5.103

4.  Coupled transcription and translation in mammalian and avian cell-free systems.

Authors:  L A Ball; C N White
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

5.  Characterization of vesicular stomatitis virus nucleocapsids. I. Complementary 40 S RNA molecules in nucleocapsids.

Authors:  M Soria; S P Little; A S Huang
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

6.  Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles.

Authors:  A S Huang; E K Manders
Journal:  J Virol       Date:  1972-06       Impact factor: 5.103

7.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

8.  Nucleotide sequences of the mRNA's encoding the vesicular stomatitis virus G and M proteins determined from cDNA clones containing the complete coding regions.

Authors:  J K Rose; C J Gallione
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

9.  Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions.

Authors:  S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

10.  Characterization and mapping of RNase III cleavage sites in VSV genome RNA.

Authors:  G W Wertz; N Davis
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

View more
  35 in total

1.  Robust kinetics of an RNA virus: Transcription rates are set by genome levels.

Authors:  Collin Timm; Ankur Gupta; John Yin
Journal:  Biotechnol Bioeng       Date:  2015-05-20       Impact factor: 4.530

2.  Synthesis of plus- and minus-strand RNA in rotavirus-infected cells.

Authors:  S Stacy-Phipps; J T Patton
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Mutations in the C-terminal loop of the nucleocapsid protein affect vesicular stomatitis virus RNA replication and transcription differentially.

Authors:  Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

4.  In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs.

Authors:  S R Carlsen; R W Peluso; S A Moyer
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

5.  Identification of a novel tripartite complex involved in replication of vesicular stomatitis virus genome RNA.

Authors:  Ashim K Gupta; Daniel Shaji; Amiya K Banerjee
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 6.  Transcription and replication of rhabdoviruses.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1987-03

7.  Characterization of bovine respiratory syncytial virus proteins and mRNAs and generation of cDNA clones to the viral mRNAs.

Authors:  R A Lerch; E J Stott; G W Wertz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species.

Authors:  Y T Huang; G W Wertz
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

9.  In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Authors:  J Erik Johnson; John W Coleman; Narender K Kalyan; Priscilla Calderon; Kevin J Wright; Jennifer Obregon; Eleanor Ogin-Wilson; Robert J Natuk; David K Clarke; Stephen A Udem; David Cooper; R Michael Hendry
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

10.  Display of disparate transcription phenotype by the phosphorylation negative P protein mutants of vesicular stomatitis virus, Indiana serotype, expressed in E. coli and eucaryotic cells.

Authors:  M Mathur; T Das; J L Chen; D Chattopadhyay; A K Banerjee
Journal:  Gene Expr       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.